SGLT2 Inhibitors-Sweet Success for Diabetic Kidney Disease?

J Am Soc Nephrol. 2017 Jan;28(1):7-10. doi: 10.1681/ASN.2016060650. Epub 2016 Aug 18.
No abstract available

Keywords: chronic kidney disease; clinical trial; diabetes mellitus; diabetic nephropathy.

Publication types

  • Editorial
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Comment

MeSH terms

  • Blood Glucose
  • Canagliflozin*
  • Diabetes Mellitus, Type 2
  • Diabetic Nephropathies
  • Disease Progression
  • Humans
  • Hypoglycemic Agents
  • Sodium-Glucose Transporter 2
  • Sodium-Glucose Transporter 2 Inhibitors*

Substances

  • Blood Glucose
  • Hypoglycemic Agents
  • Sodium-Glucose Transporter 2
  • Sodium-Glucose Transporter 2 Inhibitors
  • Canagliflozin